Premium
Immunoglobulin M indirect‐fluorescent antibody test for the diagnosis of acute toxoplasmosis during pregnancy in the avidity era: A 14‐year experience at the Tuscany Reference Center for Infectious Diseases in Pregnancy, Florence, Italy
Author(s) -
Trotta Michele,
Borchi Beatrice,
Zammarchi Lorenzo,
Sterrantino Gaetana,
Brogi Michela,
Kiros Seble Tekle,
Lorini Chiara,
Bonaccorsi Guglielmo,
Colao Maria Grazia,
Bartoloni Alessandro
Publication year - 2016
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.13144
Subject(s) - medicine , serology , toxoplasmosis , pregnancy , avidity , immunoglobulin m , antibody , immunology , direct fluorescent antibody , likelihood ratios in diagnostic testing , obstetrics , immunoglobulin g , predictive value , genetics , biology
Aim The aim of this study was to evaluate immunoglobulin M indirect‐fluorescent antibody test (IgM IFAT) for the diagnosis of acute or chronic Toxoplasma infection in pregnancy. Methods Pregnant women with suspected acute toxoplasmosis referred to the Tuscany Reference Center for Infectious Diseases in Pregnancy during the period 1998–2012 were retrospectively enrolled. All women were tested with a panel of serological tests, including enzyme‐linked immunosorbent assay for IgG avidity and IgM IFAT. On the basis of anamnestic, clinical, and serological criteria, pregnant women were classified into three groups: recently infected (RI), latently infected (LI), and doubtful latently infected (DLI). Patients classified as DLI were excluded from the analysis. The association between IgM IFAT (positive or negative) and the diagnosis of infection (acute or chronic) was assessed. Positive predictive value and negative predictive value of the IgM IFAT were calculated. Results A total of 810 pregnant women were enrolled in the study: 302 in the RI group and 508 in the LI group. Fifty‐two women classified as DLI were excluded. IgM IFAT was positive in 172 out of 302 (56.9%) pregnant women in the RI group and in 29 out of 508 (5.7%) in the LI group. The positive predictive value and negative predictive value of IgM IFAT in predicting RI was 85.6% and 78.6%, respectively. Conclusion IgM IFAT has reasonable sensitivity and specificity in diagnosing recent infection and, mostly in case of borderline avidity test, could be considered as a further aid for an accurate diagnosis of acute toxoplasmosis in pregnancy.